Browse drugs

…ow (see section on Current treatments). The antifibrotic drugs, pirfenidone and nintedanib, are established treatments for idiopathic pulmo…

…nt, and 43% worsening in perceived health status post-switch to Erelzi. Ten suspected adverse drug reactions were reported since IPC i…

…ar– Difficulties using the pen deviceProjected annual savings:– Amgevita®: £86,000– Benepali®: £34,000Conclusion Several challenges emer…

… gut graft-versus-host disease responded to corticosteroids and etanercept. On long-term follow-up, the patient remained off immunosuppres…

…arthritis was the most frequent diagnosis (30%).Drugs involved: adalimumab (35%), etanercept (25%), certolizumab (8%), belimumab (6%), ixe…

…ance to 538 patients. The most frequently dispensed drugs were: adalimumab (20.60%) and etanercept (12.40%). The most common prescribing m…

…: p=0,0482; Anti-IL12/23 vs Anti-TNF: p=0,0480; Risankizumab vs Ustekinumab: p=0,0116. No significant differences were found between Risank…

…ngle-arm trials. Fourteen studies evaluated biologic therapies: infliximab (n=5), adalimumab (n=2), etanercept (n=2), golimumab (n=1), rit…